Clinical Trial

Magnetic Resonance Imaging-guided Online Adaptive Radiotherapy of Pelvic Lymph Node Metastases

Study acronym: MACULA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In this study, the investigators want to investigate whether online-adapted radiotherapy using a special magnetic resonance imaging (MRI) simulator and computed tomography (CT)-guided radiation therapy, is feasible and offers advantages for the treatment of pelvic lymph node metastases.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2027-06 -> 2026-01-26 2026-05-12
minor Completion moved earlier: 2028-07 -> 2028-01-26 2026-05-12
Trial Details
NCT Number NCT07083648
Lead Sponsor University of Zurich
Conditions Pelvic and Para-aortic Lymph Node Metastases
Enrollment 20 participants
Start Date 2025-07-16
Primary Completion 2026-01-26 (estimated)
Study Completion 2028-01-26 (estimated)
Updated on ClinicalTrials.gov 2026-05-11